Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate Publication Conditional activation of IL-12 through a Fibronectin-EDB dependent switch gate See how QSP modeling guided the design of a reversible antibody switch that unmasks IL-12…Certara2026年7月24日
A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans Poster A novel mathematical framework to predict in vivo bispecific GTX-B001 binding in skin, and translation to humans See how quantitative pharmacology and PBPK modeling supported first in human dose selection for a…Certara2026年7月20日
Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data Publication Patient-Specific Determinants of Response to BCMA- and GPRC5D-Targeted CAR T-Cell Therapy in Multiple Myeloma: A QSP Analysis of Clinical Trial and Real-World Data QSP modeling reveals patient-specific factors driving CAR T-cell response and relapse in multiple myeloma, with…Certara2026年7月20日
Expert Q&A: Identify Winning Biotherapeutics in Early Discovery On-Demand Webinar Expert Q&A: Identify Winning Biotherapeutics in Early Discovery Watch this on-demand Q&A on using mechanistic modeling to assess feasibility and prioritize biotherapeutic candidates…Certara2026年7月17日
Integrated mechanistic modeling approaches in oncology drug development Webinar Integrated mechanistic modeling approaches in oncology drug development Certara2026年7月8日
Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies Poster Integrating Endogenous Ligand Competition into a Mechanistic Whole-Body PBPK Model of Therapeutic Monoclonal Antibodies Discover how endogenous ligand competition was incorporated into a whole-body PBPK model to improve prediction…Certara2026年6月23日
Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study Poster Application of IO Simulator in Immuno-Oncology Combination Therapy: A Small Cell Lung Cancer Case Study Learn how Certara's IO Simulator was used to predict efficacy, cytokine release syndrome risk, and…Certara2026年6月23日
Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients Publication Clinical Validation of a QSP Model for ISB 2001, a Trispecific T Cell Engager to Support Optimal FIH Study Design in RRMM Patients See how a QSP model guided efficacy-proximal FIH dosing for ISB 2001 in the TRIgnite-1…Certara2026年6月4日
Applying AI-Driven Biosimulation to Drug Discovery Video Applying AI-Driven Biosimulation to Drug Discovery Certara President Leif Pedersen explains how PBPK and QSP modeling, proven across 125+ FDA-approved drugs,…Certara2026年6月2日
Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment Publication Review: application and opportunities for machine learning and artificial intelligence in preclinical immunogenicity risk assessment This review explores how artificial intelligence (AI), machine learning (ML), and quantitative systems pharmacology (QSP)…Certara2026年6月2日